Literature DB >> 30824655

Presence of Antitopoisomerase I Antibody Alone May Not Be Sufficient for the Diagnosis of Systemic Sclerosis.

Anne E Tebo1, Robert L Schmidt1, Tracy M Frech2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30824655      PMCID： PMC7141752          DOI： 10.3899/jrheum.180503

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  10 in total

1.  Autoantibody testing for connective tissue diseases. Comparison of immunodiffusion, immunoblot, and enzyme immunoassay.

Authors:  A J Bridges; T E Lorden; T C Havighurst
Journal:  Am J Clin Pathol       Date:  1997-10       Impact factor: 2.493

2.  Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.

Authors:  S Albon; C Bunn; G Swana; Y Karim
Journal:  J Immunol Methods       Date:  2010-12-22       Impact factor: 2.303

Review 3.  Scleroderma.

Authors:  Armando Gabrielli; Enrico V Avvedimento; Thomas Krieg
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

4.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

5.  A cross-reactive idiotype in scleroderma.

Authors:  D Vázquez-Abad; L Tian; M Zanetti; N F Rothfield
Journal:  Clin Exp Immunol       Date:  1997-06       Impact factor: 4.330

6.  Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.

Authors:  Sarada L Nandiwada; Lisa K Peterson; Maureen D Mayes; Troy D Jaskowski; Elisabeth Malmberg; Shervin Assassi; Minoru Satoh; Anne E Tebo
Journal:  J Rheumatol       Date:  2016-08-01       Impact factor: 4.666

Review 7.  Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.

Authors:  Eduardo J Cepeda; John D Reveille
Journal:  Curr Opin Rheumatol       Date:  2004-11       Impact factor: 5.006

8.  Scl 70 antibody--a specific marker of systemic sclerosis.

Authors:  M Jarzabek-Chorzelska; M Blaszczyk; S Jablonska; T Chorzelski; V Kumar; E H Beutner
Journal:  Br J Dermatol       Date:  1986-10       Impact factor: 9.302

9.  There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Authors:  S R Johnson; M L Soowamber; J Fransen; D Khanna; F Van Den Hoogen; M Baron; M Matucci-Cerinic; C P Denton; T A Medsger; P E Carreira; G Riemekasten; J Distler; A Gabrielli; V Steen; L Chung; R Silver; J Varga; U Müller-Ladner; M C Vonk; U A Walker; F A Wollheim; A Herrick; D E Furst; L Czirjak; O Kowal-Bielecka; F Del Galdo; M Cutolo; N Hunzelmann; C D Murray; I Foeldvari; L Mouthon; N Damjanov; B Kahaleh; T Frech; S Assassi; L A Saketkoo; J E Pope
Journal:  Scand J Rheumatol       Date:  2017-10-09       Impact factor: 3.641

10.  Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.

Authors:  K A Patterson; P J Roberts-Thomson; S Lester; J A Tan; P Hakendorf; M Rischmueller; J Zochling; J Sahhar; P Nash; J Roddy; C Hill; M Nikpour; W Stevens; S M Proudman; J G Walker
Journal:  Arthritis Rheumatol       Date:  2015-12       Impact factor: 10.995
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.